Literature DB >> 8494695

Opposing behavioural alterations in male and female transgenic TGF alpha mice: association with tumour susceptibility.

L A Hilakivi-Clarke1, P K Arora, R Clarke, A Wright, M E Lippman, R B Dickson.   

Abstract

Psychosocial factors are thought to influence risk and survival from cancer. We have previously studied specific behaviours in transgenic male CD-1 MT42 mice, which overexpress the gene encoding human transforming growth factor alpha (TGF alpha) in multiple tissues, and which develop a high incidence of spontaneous hepatocellular carcinoma. The male TGF alpha mice spent a lengthened time immobile in the swim test, were highly aggressive, had increased plasma levels of 17 beta-estradiol (E2), and reduced natural killer (NK) cell activity. The female transgenic MT42 TGF alpha mice do not develop an increased rate of tumours at any site. We hypothesised that if the alterations in male TGF alpha mice are associated with their development of hepatocellular carcinomas, female TGF alpha should not show these alterations. The data in the present study indicate that female TGF alpha mice display shortened immobility in the swim test, suggesting an improved ability to cope with stress, and appear less aggressive in the resident-intruder test than non-transgenic female CD-1 mice. The female TGF alpha mice also exhibit a 3-fold increase in the plasma levels of E2, and a 3-fold increase in NK cell activity. These findings suggest that the elevated expression of TGF alpha in the transgenic mice is associated with gender-specific behavioural alterations, and the development of spontaneous hepatocellular tumours in the males. Furthermore, TGF alpha alters hormonal and immune parameters similarly in both sexes. It remains to be determined whether the development of hepatocarcinoma in the male TGF alpha animals is associated with an impaired ability to cope with stress and elevated aggressive tendencies and/or whether manipulations leading to an impaired ability to cope with stress will promote tumourigenesis in female TGF alpha mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494695      PMCID: PMC1968449          DOI: 10.1038/bjc.1993.188

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

Review 1.  Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions.

Authors:  R Clarke; R B Dickson; M E Lippman
Journal:  Crit Rev Oncol Hematol       Date:  1992-01       Impact factor: 6.312

2.  Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesis.

Authors:  J D Yager; Y E Shi
Journal:  Prev Med       Date:  1991-01       Impact factor: 4.018

Review 3.  Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview.

Authors:  C N d'Arville; P J Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  1990-12-20       Impact factor: 4.292

4.  Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma.

Authors:  M Shirai; S Watanabe; M Nishioka
Journal:  Hepatogastroenterology       Date:  1990-10

5.  Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression.

Authors:  L A Hilakivi-Clarke; K M Wozniak; M J Durcan; M Linnoila
Journal:  Physiol Behav       Date:  1990-09

6.  Life events prior to manifestation of breast cancer: a limited prospective study covering eight years before diagnosis.

Authors:  S Geyer
Journal:  J Psychosom Res       Date:  1991       Impact factor: 3.006

7.  Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma.

Authors:  T Saibara; S Onishi; H Sakaeda; Y Yamamoto
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

8.  Behavioral despair in mice: a primary screening test for antidepressants.

Authors:  R D Porsolt; A Bertin; M Jalfre
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-10

9.  Alterations in behavior, steroid hormones and natural killer cell activity in male transgenic TGF alpha mice.

Authors:  L A Hilakivi-Clarke; P K Arora; M B Sabol; R Clarke; R B Dickson; M E Lippman
Journal:  Brain Res       Date:  1992-08-14       Impact factor: 3.252

10.  Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.

Authors:  S C Liu; B Sanfilippo; I Perroteau; R Derynck; D S Salomon; W R Kidwell
Journal:  Mol Endocrinol       Date:  1987-10
View more
  2 in total

Review 1.  Psychosocial factors in the development and progression of breast cancer.

Authors:  L Hilakivi-Clarke; J Rowland; R Clarke; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

Review 2.  Perinatal factors increase breast cancer risk.

Authors:  L Hilakivi-Clarke; R Clarke; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.